These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26130503)

  • 1. The B subunit of Escherichia coli heat-labile toxin alters the development and antigen-presenting capacity of dendritic cells.
    Ji J; Griffiths KL; Milburn PJ; Hirst TR; O'Neill HC
    J Cell Mol Med; 2015 Aug; 19(8):2019-31. PubMed ID: 26130503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4(+) T cells.
    Nashar TO; Betteridge ZE; Mitchell RN
    Int Immunol; 2001 Apr; 13(4):541-51. PubMed ID: 11282993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The B subunit of Escherichia coli heat-labile enterotoxin induces both caspase-dependent and -independent cell death pathways in CD8+ T cells.
    Salmond RJ; Williams R; Hirst TR; Williams NA
    Infect Immun; 2004 Oct; 72(10):5850-7. PubMed ID: 15385486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells.
    Luross JA; Heaton T; Hirst TR; Day MJ; Williams NA
    Arthritis Rheum; 2002 Jun; 46(6):1671-82. PubMed ID: 12115200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholera toxin and Escherichia coli enterotoxin B-subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments.
    Millar DG; Hirst TR
    Cell Microbiol; 2001 May; 3(5):311-29. PubMed ID: 11298654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of B lymphocyte signalling by the B subunit of Escherichia coli heat-labile enterotoxin.
    Bone H; Eckholdt S; Williams NA
    Int Immunol; 2002 Jun; 14(6):647-58. PubMed ID: 12039916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective CD8(+) T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells.
    Fu N; Khan S; Quinten E; de Graaf N; Pemberton AJ; Rivett AJ; Melief CJ; Ossendorp F
    Vaccine; 2009 Aug; 27(38):5252-8. PubMed ID: 19576942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1.
    Nashar TO; Hirst TR; Williams NA
    Immunology; 1997 Aug; 91(4):572-8. PubMed ID: 9378497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli enterotoxin B subunit triggers apoptosis of CD8(+) T cells by activating transcription factor c-myc.
    Soriani M; Williams NA; Hirst TR
    Infect Immun; 2001 Aug; 69(8):4923-30. PubMed ID: 11447169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal delivery of antigen with the B subunit of Escherichia coli heat-labile enterotoxin augments antigen-specific T-cell clonal expansion and differentiation.
    Apostolaki M; Williams NA
    Infect Immun; 2004 Jul; 72(7):4072-80. PubMed ID: 15213152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions.
    Fraser SA; de Haan L; Hearn AR; Bone HK; Salmond RJ; Rivett AJ; Williams NA; Hirst TR
    Infect Immun; 2003 Mar; 71(3):1527-37. PubMed ID: 12595472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis.
    Raveney BJ; Richards C; Aknin ML; Copland DA; Burton BR; Kerr E; Nicholson LB; Williams NA; Dick AD
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4008-17. PubMed ID: 18469197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli.
    Liang S; Hosur KB; Nawar HF; Russell MW; Connell TD; Hajishengallis G
    Vaccine; 2009 Jul; 27(32):4302-8. PubMed ID: 19450646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin.
    Millar DG; Hirst TR; Snider DP
    Infect Immun; 2001 May; 69(5):3476-82. PubMed ID: 11292779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.
    Hu JC; Mathias-Santos C; Greene CJ; King-Lyons ND; Rodrigues JF; Hajishengallis G; Ferreira LC; Connell TD
    PLoS One; 2014; 9(12):e113978. PubMed ID: 25536061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvants LT-K63 and CpG enhance the activation of dendritic cells in neonatal mice.
    Hannesdottir SG; Olafsdottir TA; Giudice GD; Jonsdottir I
    Scand J Immunol; 2008 Nov; 68(5):469-75. PubMed ID: 18946928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxin.
    Chen CG; Lu YT; Lin M; Savelyeva N; Stevenson FK; Zhu D
    Vaccine; 2009 Jul; 27(32):4289-96. PubMed ID: 19450635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences.
    Turcanu V; Hirst TR; Williams NA
    Immunology; 2002 Jul; 106(3):316-25. PubMed ID: 12100719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B
    Lee CH; Hajishengallis G; Connell TD
    J Microbiol Biotechnol; 2017 Apr; 27(4):709-717. PubMed ID: 28144014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presenting capacity of murine splenic myeloid cells.
    Hey YY; Quah B; O'Neill HC
    BMC Immunol; 2017 Jan; 18(1):4. PubMed ID: 28077081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.